Advertisement
Advertisement

GRI

GRI logo

GRI Bio, Inc. Common Stock

1.84
USD
Sponsored
-0.02
-1.08%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

1.89

+0.05
+2.72%

GRI Bio, Inc. Common Stock Profile

About

GRI Bio Inc. is a clinical stage biopharmaceutical company which focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI Bio Inc., formerly known as Vallon Pharmaceuticals Inc., is based in PHILADELPHIA, PA.

Info & Links

CEO

W. Marc Hertz

Headquarters

2223 AVENIDA DE LA PLAYA,SUITE 208
LA JOLLA, CA 92037, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://www.gribio.com/

Auditor

WithumSmith+Brown, PC

Share holders

5

Employees

4

GRI Bio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

3.35M

Enterprise Value

-7.70M

Enterprise Value/EBITDA(ttm)

0.70

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.57

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-381.74%

Return on Invested Capital(ttm)

-552.63%

Return on Assets(ttm)

-206.45%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-10.93M

Net Income Available to Common(ttm)

-10.91M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

-1.34

52-Week Change

-94.98%

S&P 500 52-Week Change

20.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

1.77M

Dividend Yield

0.00%

Float4

1.32M

% Held by Insiders

8.73%

% Held by Institutions

33.95%

Balance Sheet

Total Cash(mrq)

11.05M

Total Cash Per Share(mrq)

6.24

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

3.25%

Quick Ratio(mrq)

3.25%

Book Value Per Share(mrq)

12.06

Cash Flow

Operating Cash Flow Per Share(ytd)

-103.77

Free Cash Flow(ytd)

-10.19M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement